Us Congress 2023-2024 Regular Session

Us Congress Senate Bill SB2364

Introduced
7/18/23  

Caption

MAPS Act Mapping America's Pharmaceutical Supply Act

Impact

If enacted, SB2364 could significantly modify federal approaches to drug safety and availability. The creation of a centralized database could facilitate improved monitoring of the pharmaceutical supply chain, potentially reducing the risks of drug shortages during public health emergencies. Additionally, the act reinforces the federal government's role in overseeing pharmaceutical distribution, which may result in enhanced cooperation between government entities and private sector partners.

Summary

The 'Mapping America's Pharmaceutical Supply Act' or SB2364 aims to enhance the United States' oversight of its pharmaceutical supply chain. It mandates a comprehensive mapping of the entire supply chain, from production to distribution, to identify potential vulnerabilities and threats to national security. The bill proposes that the Secretary of Health and Human Services collaborate with other federal agencies, including Defense and Homeland Security, to develop a database listing essential medicines and their associated active ingredients, with the aim of ensuring a robust public health response in emergencies.

Contention

While many advocates praise SB2364 for its potential to improve public health infrastructure, there are concerns regarding the implications of data sharing between agencies. The bill ensures that confidential commercial information is protected and not publicly disclosed, raising questions about transparency and accountability. Critics may also argue about the adequacy of resources to implement such a comprehensive mapping and database system effectively, which could lead to gaps in addressing supply chain vulnerabilities.

Notable_points

One significant aspect of SB2364 is its focus on predictive analytics to anticipate potential drug shortages or threats. This proactive approach aims to enhance national preparedness for public health crises. However, the effectiveness of the proposed mapping and data analytics heavily depends on industry cooperation, which suggests that collaboration between the public and private sectors will be vital for the bill's success.

Companion Bills

No companion bills found.

Previously Filed As

US SB1784

MAPS Act Mapping America's Pharmaceutical Supply Act

US SB2062

RAPID Reserve Act Rolling Active Pharmaceutical Ingredient and Drug Reserve Act

US HB3955

RAPID Reserve Act Rolling Active Pharmaceutical Ingredient and Drug Reserve Act

US HB1060

Modern Authentication of Pharmaceuticals Act of 2025

US HB1768

Lower Costs for Everyday Americans Act Nationwide Consumer and Fuel Retailer Choice Act Recycling and Composting Accountability Act SUPPORT for Patients and Communities Reauthorization Act of 2025 American Music Tourism Act Deploying American Blockchains Act

US HB2444

Promoting Resilient Supply Chains Act of 2025

US SB257

Promoting Resilient Supply Chains Act of 2025

US SB99

Strengthening Support for American Manufacturing Act

US HB900

Sinkhole Mapping Act of 2025

US SB998

Medical Supply Chain Resiliency Act

Similar Bills

No similar bills found.